ImmunoGen
IMGN
#2144
Rank
A$13.13 B
Marketcap
A$47.02
Share price
0.00%
Change (1 day)
127.33%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: A$13.13 Billion

On April 12, 2024 ImmunoGen had a market cap of A$13.13 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024A$14.02 B20.41%
2023A$11.64 B623.97%
2022A$1.60 B-28.58%
2021A$2.25 B37.93%
2020A$1.63 B49.2%
2019A$1.09 B7.54%
2018A$1.01 B-6.25%
2017A$1.08 B339.49%
2016A$0.24 B-84.76%
2015A$1.62 B152.7%
2014A$0.64 B-54.44%
2013A$1.40 B36.34%
2012A$1.03 B19.65%
2011A$0.86 B39.2%
2010A$0.62 B23.67%
2009A$0.50 B62.36%
2008A$0.30 B51.66%
2007A$0.20 B-23.96%
2006A$0.26 B-7.02%
2005A$0.28 B-38.24%
2004A$0.46 B69.11%
2003A$0.27 B18.76%
2002A$0.23 B-82.03%
2001A$1.29 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
A$64.96 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$267.43 B 1,936.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.363 T 10,281.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$159.83 B 1,116.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$732.43 B 5,476.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$222.81 B 1,596.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$381.77 B 2,806.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$182.01 B 1,285.78%๐Ÿ‡ซ๐Ÿ‡ท France